Opiate Substitution Treatment
9
0
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
22%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (9)
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
A Chatbot To Support Substance Use Recovery
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder
Extended-release Pharmacotherapy for Opioid Use Disorder
Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence